Physician profile
Babar Shareef
NPI 1861493538
$3,676.84
in general payments reported to CMS, 2019-2025
22 companies · $443 in 2025
The $443 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $537 · 2020: $117 · 2021: $665 · 2022: $727 · 2023: $551 · 2024: $637 · 2025: $443.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,631.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,630.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $467.36 | 2021-2025 | Aveir, Amplatzer Amulet |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $396.74 | 2019-2025 | Lifevest |
| Amgen INC. | $393.52 | 2019-2024 | Repatha |
| Pfizer INC. | $348.55 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $347.37 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $323.62 | 2019-2025 | Eliquis, Camzyos |
| Boston Scientific Corporation | $214.89 | 2022-2025 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Kestra Medical Technology Services, INC. | $196.71 | 2024-2025 | Assure Wcd |
| Sanofi-Aventis U.S. LLC | $196.51 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $136.00 | 2019-2023 | Xarelto |
| Astellas Pharma US INC | $130.49 | 2019-2021 | |
| Abiomed | $125.01 | 2021 | |
| Merck Sharp & Dohme LLC | $74.71 | 2022-2023 | Verquvo |
| Medtronic, INC. | $71.44 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $61.16 | 2019-2023 | Farxiga |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $39.39 | 2022 | |
| Baxter Healthcare | $34.43 | 2024-2025 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Cvrx, INC. | $33.97 | 2023 | Barostim Neo System |
| Lexicon Pharmaceuticals, INC. | $22.91 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $22.07 | 2019 | |
| Amarin Pharma, INC. | $20.71 | 2019 | |
| Chiesi USA, INC. | $19.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Babar Shareef listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.